Starter protocol · Free
The The Post-GLP-1 Plateau Protocol
Recently stopped a GLP-1. The rebound is structural — here's how to blunt it.
What's actually happening
The STEP 1 trial extension (Wilding 2022) documented that one year after stopping semaglutide, two-thirds of weight was regained and most cardiometabolic improvements reversed. The mechanism: the drug suppressed appetite pharmacologically; when it stops, appetite returns — often stronger because leptin levels are now lower and ghrelin higher (set-point defense). Linge 2024's body-composition substudy documented 25–40% of total weight lost on semaglutide is lean mass — a sarcopenia risk especially relevant for women and older adults. Jensen 2024 showed GLP-1 monotherapy reduced bone mineral density at hip and spine; concurrent exercise prevented this. The rebound is not a personal failure — it's the rule documented in trial data. The protocol substitutes structural lifestyle interventions for the pharmacological appetite suppression, plus actively addresses the lean-mass and bone deficit accumulated during on-drug time.¹Diabetes, Obesity and Metabolism · 2022Wilding JPH et al. — Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension²Obesity Reviews · 2024Linge J et al. — Body composition and cardiometabolic effects of GLP-1 receptor agonists: changes in lean mass³JAMA Network Open · 2024Jensen SBK et al. — Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment⁴Annals of Internal Medicine · 2004Spiegel K et al. — Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite⁵Journal of Sports Sciences · 2011Phillips SM, Van Loon LJC — Dietary protein for athletes: from requirements to optimum adaptation
The four things to fix first
01
Protein at 1.9 g/kg, distributed
Critical: lean mass loss continues post-discontinuation if protein and resistance training don't replace the suppressed appetite. 1.9 g/kg per day, split across 4 small meals (your appetite is rebounding but distribution still matters).
02
Resistance training 3x/week, immediately
Jensen 2024 showed exercise prevented the bone-density loss; it also drives lean-mass rebuild. This isn't optional. Compound lifts, progressive overload, 3 sessions/week minimum.
03
Drop UPF aggressively
Your appetite is now higher than pre-drug baseline. UPF will exploit it. Run the UPF Score Calculator weekly. Replace UPF anchors with protein-and-plant alternatives. This is the substitute appetite-suppression mechanism.
04
Sleep optimization is now critical
Sleep loss further amplifies appetite (Spiegel 2004). Coming off a GLP-1, you cannot afford to also be sleep-deprived. 8 hours nightly, consistent bedtime, no food 3 hours before bed.
Week 1 – 2 starter plan
- 1.9 g/kg protein in 4 meals
- 3 strength sessions
- Walk 10,000+ steps daily
- UPF audit weekly
- 8 hours sleep, consistent
- No food after 7:30pm
What to track
- ·Weight (weekly, expect some rebound — don't panic)
- ·Strength progression
- ·Protein grams daily
- ·UPF % weekly
- ·Energy 1–10
When to consider the full program
This starter protocol gets you from zero to functional in 2–4 weeks. If you want the structured 12-week curriculum — daily lessons, meal plans, video guidance, community accountability — see the Ancestral Reset.
References
- 1.Wilding JPH et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism. PubMed 35441470
- 2.Linge J et al. (2024). Body composition and cardiometabolic effects of GLP-1 receptor agonists: changes in lean mass. Obesity Reviews. PubMed 38605467
- 3.Jensen SBK et al. (2024). Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment. JAMA Network Open. PubMed 38904957
- 4.Spiegel K et al. (2004). Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of Internal Medicine. PubMed 15583226
- 5.Phillips SM, Van Loon LJC (2011). Dietary protein for athletes: from requirements to optimum adaptation. Journal of Sports Sciences. PubMed 22150425
Free · 2 minutes
Not sure if this is your profile?
The Metabolic Damage Assessment maps your specific answers to the right protocol — including the cases where two patterns overlap.